0001562180-21-004349.txt : 20210617 0001562180-21-004349.hdr.sgml : 20210617 20210617160831 ACCESSION NUMBER: 0001562180-21-004349 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20210615 FILED AS OF DATE: 20210617 DATE AS OF CHANGE: 20210617 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: LYNCH DANIEL CENTRAL INDEX KEY: 0001177082 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-35966 FILM NUMBER: 211024786 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: bluebird bio, Inc. CENTRAL INDEX KEY: 0001293971 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 60 BINNEY STREET CITY: CAMBRIDGE STATE: MA ZIP: 02142 BUSINESS PHONE: 339-499-9300 MAIL ADDRESS: STREET 1: 60 BINNEY STREET CITY: CAMBRIDGE STATE: MA ZIP: 02142 FORMER COMPANY: FORMER CONFORMED NAME: Genetix Pharmaceuticals Inc DATE OF NAME CHANGE: 20040616 4 1 primarydocument.xml PRIMARY DOCUMENT X0306 4 2021-06-15 false 0001293971 bluebird bio, Inc. BLUE 0001177082 LYNCH DANIEL C/O BLUEBIRD BIO, INC. 60 BINNEY STREET CAMBRIDGE MA 02142 true false false false Common Stock 2021-06-15 4 A false 4353.00 0.00 A 12312.00 D Stock Option (right to buy) 32.83 2021-06-15 4 A false 7000.00 0.00 A 2031-06-15 Common Stock 7000.00 7000.00 D These restricted stock units for common stock vest 100% on the earlier of June 15, 2022 or the date of the next annual meeting of stockholders. This option vests 100% on the earlier of June 15, 2022 or the date of the next annual meeting of stockholders. /s/ Jason F. Cole, Attorney-in-Fact 2021-06-17